Healthtech capital ecosystem and value

About HealthTech Capital

Founded in 2010, the HealthTech Capital Membership is comprised of successful entrepreneurs, executives, clinicians, and large corporate venture groups.  Based in Silicon Valley,  we have  angel investors nationwide and use web-based tools for data access and real time video streaming of our screening dinners and due diligence meetings.

Angels

Corporate

Corporate

healthtech capital angel investor

  Our angel investors’ expertise covers Digital Health, Pharmaceuticals & Therapeutics, Medical Device & Instrumentation, Drug Discoveries, Diagnostics, Healthcare Services and Clinical Care delivery.  

Corporate

Corporate

Corporate

healthtech capital corporate members

 Our Corporate Members cover all healthcare stakeholders from Providers to Payers to large healthcare Corporations. We help our Industry Members stay abreast of cutting-edge innovation for potential partnerships or investments.

Mentoring

Corporate

Mentoring

healthtech capital mentoring

 HTC does not charge any application or presentation fees. We  may offer our Mentorship Program to add significant value to companies, such as strategic advice, industry connections and business model coaching. 

Founder

 HealthTech Capital founder is a well-known thought leader and pioneer with a  track record in building HealthTech companies.

Anne DeGheest, founder, healthtech capital

Anne DeGheest

Anne DeGheest pioneered the HealthTech or Digital Health space as a healthcare executive, an entrepreneur, angel investor, corporate advisor and mentor capitalist... over the last 30 years!

Her life science portfolio companies have generated over $18 billion in market capitalization including 8 IPOs.  Anne has startup operating experience as CEO and VP and has served on public and private boards. Anne earned an MS from University of Brussels, and an MBA from Harvard. 

Selection Committee

 HealthTech capital angel investors serve for rotating terms on the Selection Committee. 

During our monthly cycle, we review portal submissions during the first week of each month and invite the top 4 companies to present on the third Tuesday at our screening dinner. 

HTC Selection Committee

Anne DeGheest, healthtech capital

Anne DeGheest

Carl Bouthillette

Anne DeGheest

Ben lenail, healthtech capital screening

Ben Lenail

Carl Bouthillette

Anne DeGheest

Carl Bouthillette, healthtech capital , screening committee

Carl Bouthillette

Carl Bouthillette

Carl Bouthillette

Cris Wedekind, HealthTech capital selection committee

Cris Wedekind

Michelle Mullany

Carl Bouthillette

Michelle Mullany, healthtech capital selection committee

Michelle Mullany

Michelle Mullany

Michelle Mullany

Matt Merkert, Healthtech capital selection committee

Matt Merkert

Michelle Mullany

Michelle Mullany

Tim Dang, Healthtech capital selection committee

Tim Dang

Lila Taylor

Lila Taylor

Lila Taylor, Healthtech capital selection committee

Lila Taylor

Lila Taylor

Lila Taylor

Analyst-in-Residence Program

Our Analyst-in-Residence Program (AiR) is an educational program for post-graduate professionals that are passionate about healthcare technology. AiRs help with HTC operations and research in exchange for invaluable learning about early-stage investing, due diligence, and portfolio management. 

Operating Managers

Nichole Khan, healthtech capital operating manager

Nichole Khan

Sea-Jay Van der Ploeg

Sea-Jay Van der Ploeg

AiRs and Operation Director

Sea-Jay Van der Ploeg, HealthTech capital operation manager

Sea-Jay Van der Ploeg

Sea-Jay Van der Ploeg

Sea-Jay Van der Ploeg

Operation Manager 

Contact Us

Contact HealthTech Capital

HealthTech Capital

Los Altos Hills, California